NCT04410367 2025-07-20
PURSUE
Blue Earth Diagnostics
Phase 2 Completed
Clinical Trials
8 trialsNCT04535414 2025-01-17
Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03648879 2021-07-12
Confocal Endoscopic Microscopy for Detection of Early Stage Gastric Cancer in Subjects With Hereditary Diffuse Gastric Cancer Syndrome
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01262027 2019-07-30
TKI258 for Metastatic Inflammatory Breast Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03185182 2019-06-21
RCCSCAN
Region Skane
Phase 2 Terminated
NCT00788892 2018-01-12
Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
Jazz Pharmaceuticals
Phase 2 Completed
NCT00284141 2012-12-10
Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma
Sanofi
Phase 2 Completed
NCT00784849 2012-06-20
Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)
Louisiana State University Health Sciences Center in New Orleans
Phase 2 Completed